Winter Boosts Vaccine Response in Temperate Regions
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Laura Barrero Guevara and her NYU team pooled data from 96 randomized controlled trials involving roughly 48,000 children vaccinated against 14 infections worldwide.
- Temperate regions showed a clear winter peak in antibody levels after vaccination, indicating a latitudinal gradient linked to day‑length changes.
- Tropical regions displayed irregular seasonal swings, with some vaccines such as rotavirus and polio having larger fluctuations but peaks that varied by vaccine type.
- Researchers excluded participants who already possessed antibodies, minimizing the chance that recent infection drove the observed seasonal patterns.
- Cathy Wyse of the University of Edinburgh said the findings suggest humans possess an innate seasonal timing of immune function, akin to other animals.
Why it matters: Public health agencies can use the 48,000‑child study to schedule shots in winter for temperate regions, boosting antibody levels and cutting disease incidence, while manufacturers can adjust trial designs to account for seasonal efficacy.
